Ep. 6 Percutaneous Ventricular Assist Devices (pVADs) with Dr. Babar Basir

It’s no shock that percutaneous ventricular assist devices (pVADs) play an important role in improving cardiogenic shock outcomes (pun intended). In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo interviews Dr. Babar Basir, a renowned interventional cardiologist from Michigan, about advancements and protocols in managing cardiogenic shock. --- SYNPOSIS Dr. Babar Basir details the history and development of the cardiogenic shock program initiated at Henry Ford Hospital, its national expansion, and its impact on patient outcomes. The conversation touches on the role of advanced heart failure specialists, ongoing trials like the Door to Unload trial, and the importance of small bore mechanical circulatory support devices. Dr. Babar Basir also highlights the significance of team-based approaches and the necessity of multidisciplinary care in improving survival rates for patients suffering from cardiogenic shock. --- TIMESTAMPS 00:00 - Introduction03:50 - Impella in Shock: From Last-Resort to Early Use 07:30 - National Cardiogenic Shock Initiative 14:30 - Heart Failure Readmissions 17:46 - Additional Indications for Use of Impella Device 24:10 - Future Devices and Technological Advancements in the Field27:03 - International Advancements in Shock Initiative Protocols30:28 - Using Impella CP vs Impella 5.5 38:20 - SCAI Shock Conference and Importance of Attending --- RESOURCES Dr. Sameh Sayfo:https://www.bswhealth.com/physician/sameh-sayfo Dr. Babar Basir:https://www.henryford.com/physician-directory/b/basir-mir National Cardiogenic Shock Initiativehttps://www.henryford.com/cardiogenicshock Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction (also known as “Door to Unload Trial”):https://pubmed.ncbi.nlm.nih.gov/30586728/ Upcoming SCAI Shock Conference September 18th-20th, 2025https://scai.org/education-and-events/events-schedule/2025-scai-shock-0

There are no comments yet.

Please log in to write the first comment.